novo nordisk lawsuit semaglutide expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" Novo Nordisk suing Hims &
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists have been demonstrated to exert anti-inflammatory and neuroprotective effects, making these drugs particularly exciting prospects in the treatment of MS
There is no trial evidence that retatrutide builds muscle or is anabolic
There's research suggesting an association between estrogen and cognitive function, and the timing hypothesis is relevant here too: early initiation of HRT is studied differently than late initiation for cognitive outcomes
Anovulatory cycles can be associated with either low or, by contrast, constantly elevated estradiol levels (53)
